Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

174 G/C interleukin 6 genotype is related to higher risk of graft loss and GFR decline in 5-year observation in kidney graft recipients

U Siekiera, J Chudek, A Kolonko, M Szotowska, H Karkoszka, L Cierpka, A Więcek

Ann Transplant 2009; 14(1): 38-38 :: ID: 880336

Abstract

Background: Polymorphisms of TNF-alfa, IL-10, IL-6, IFN-gamma and TGF-b1
genes are related to the constitutional gene expression and production of appropriate cytokines. The aim of this study was to assess the impact of TNF-alfa, IL-10, IL-6, and IFN-gamma genotypes on GFR and long-term kidney graft outcome.
Material/Methods: Genotyping was performed in 240 subsequent kidney graft recipients from 1998 to 2002. Genomic DNA was obtained from peripheral leukocytes. Identification of cytokine genotypes was based on PCR-SSP  method for TNF-alfa at position -308 A/G, IL-10 at positions -1082 A/G, -819 T/C, -592 A/C, IL-6 at position -174 G/C, IFN-gamma at position +874 T/A and TGFb1in codon 10 (T/C) and 25 (G/C). Genotypes were grouped according to the strength of cytokines expression. Nineteen patients with primary graft nonfunction were excluded from the analysis. During 5-year follow up period 17 patients died with functioning graft and 35 patients developed graft failure. Glomerular filtration rate (eGFR) was estimated based on MDRD equation. The yearly eGFR decline was calculated from 6 months to 5 years follow-up period.
Results: Only IL-6 gene polymorphism had signifi cant impact on kidney graft
survival and decline of eGFR. In patients with CC genotype (determining low IL-6 production) only 6 out of 68 patients (8.8%) lost kidney graft while in the group with GG and GC genotypes (determining higher IL-6 production) 29 out of 151 patients (19.2%). The risk of graft loss (hazard ratio) was 2.38 (1.01-4.16), p=0.046 for GG or GC carriers. The frequency of death was
similar in both groups (7.3 and 7.9%). eGFR decline was significantly faster
in GG or GC carriers [-4.61 (-6.01- -3.21) ml/min/year] than CC carriers
[-2.07 (-3.27- -0.88) ml/min/year], p=0.02.
Conclusions: IL-6 genotypes of the kidney recipient, determining higher IL-6
constitutional expression, are related to the increased risk of graft loss.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

08 Mar 2024 : Original article  

Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...

Ann Transplant In Press; DOI: 10.12659/AOT.943532  

14 Mar 2024 : Original article  

Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort Study

Ann Transplant In Press; DOI: 10.12659/AOT.943652  

14 Mar 2024 : Case report  

Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...

Ann Transplant In Press; DOI: 10.12659/AOT.942358  

15 Mar 2024 : Review article  

Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...

Ann Transplant In Press; DOI: 10.12659/AOT.941185  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358